The Future of Gene Editing with Jennifer Doudna
Original Report
Emily Chang meets Nobel Prize-winning scientist and University of California, Berkeley, Professor Jennifer Doudna to discuss the origins of CRISPR, other breakthroughs in gene editing and what...
Emily Chang meets Nobel Prize-winning scientist and University of California, Berkeley, Professor Jennifer Doudna to discuss the origins of CRISPR, other breakthroughs in gene editing and what Silicon Valley gets wrong about the future of biology. (Source: Bloomberg)
Glass House Analysis
This story reflects the interconnected nature of modern economic systems, where developments in one sector inevitably affect others. Understanding these connections is essential for grasping how policy decisions and market movements translate into real-world outcomes for families, workers, and communities. The economy is not an abstract system of numbers—it's the sum total of decisions about who works, who prospers, and who struggles.
The implications extend beyond the immediate news cycle. Every economic development creates ripples that affect employment, prices, and opportunities in ways that may not be immediately visible but are deeply felt. By tracking these connections, we can better understand how the economy truly works—not as an abstract machine, but as a human system shaped by and shaping the lives of millions.
Enjoyed this analysis?
Get the Glass House Briefing every morning—market news that actually makes sense, delivered free to your inbox.
No spam. Unsubscribe anytime.
More Stories
S&P 500 ticks higher as chip stocks bounce from sell-off, oil slides: Live updates
The S&P 500 moved slightly higher on Wednesday after oil prices fell and technology stocks rebounded.
Wendy's stock soars as meme traders target another turnaround play
While management changes can influence investor sentiment, the magnitude of the move suggests other forces may be at play.
‘It feels like a medical miracle’: How did a single QR code coupon cut my $618 Walgreens prescription to $15?
“This medication was generic.”
Qualcomm inks deal for AI startup Modular to bolster software stack, data center buildout
Qualcomm is looking to expand its position in the data center market as AI demand skyrockets.